{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:44:29Z","timestamp":1715319869072},"reference-count":39,"publisher":"IntechOpen","license":[{"start":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:00:00Z","timestamp":1555113600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.5772\/intechopen.85258","type":"book-chapter","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T12:49:44Z","timestamp":1556628584000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis of Multiple Sclerosis"],"prefix":"10.5772","author":[{"given":"Joyce","family":"Pauline Joseph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3774","published-online":{"date-parts":[[2019,4,13]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy In multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Annals of the New York Academy of Sciences. 1965;122:552-568","DOI":"10.1111\/j.1749-6632.1965.tb20235.x"},{"key":"ref=2","unstructured":"Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Annals of Neurology. Mar 1983;13(3):227-231"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald criteria. Annals of Neurology. 2005;58(6):840-846. CiteSeerX 10.1.1.604.2677. DOI: 10.1002\/ana.20703. PMID 16283615","DOI":"10.1002\/ana.20703"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology. 2011;69(2):292-302. DOI: 10.1002\/ana.22366. PMC: 3084507. PMID: 21387374","DOI":"10.1002\/ana.22366"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology. 2018;17(2):162-173","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology. 2014;83(3):278-286","DOI":"10.1212\/WNL.0000000000000560"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Balcer LJ. Clinical practice. Optic neuritis. The New England Journal of Medicine. 2006;354(12):1273-1280","DOI":"10.1056\/NEJMcp053247"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Hickman SJ, Dalton CM, Miller DH. Management of acute optic neuritis. Lancet. 2002;360:1953-1962","DOI":"10.1016\/S0140-6736(02)11919-2"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Beck RW, Cleary PA, Anderson MM. A randomized controlled trial of corticosteroids in the treatment of acute optic neuritis. The New England Journal of Medicine. 1992;326:581-588","DOI":"10.1056\/NEJM199202273260901"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Soderstrom M. Optic neuritis and multiple sclerosis. Acta Ophthalmologica Scandinavica. 2001;79:223-227","DOI":"10.1034\/j.1600-0420.2001.790302.x"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Optic Neuritis Study Group. The clinical profile of optic neuritis: Experience of the Optic Neuritis Treatment Trial. Archives of Ophthalmology. 1991;109:1673-1678","DOI":"10.1001\/archopht.1991.01080120057025"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Lee AG, Brazis PW. Clinical Pathways in Neuro-Ophthalmology: An Evidence-Based Approach. New York: Thieme Medical Publishers; 2003","DOI":"10.1055\/b-002-51010"},{"key":"ref=13","unstructured":"Compston A, McDonald I, Noseworthy J, Lassmann H, Miller D, Smith K, et al. McAlpine's Multiple Sclerosis. 4th ed2005"},{"key":"ref=14","unstructured":"Swingler RJ, Compston DA. The morbidity of multiple sclerosis. The Quarterly Journal of Medicine. 1992;83(300):325-337"},{"key":"ref=15","unstructured":"Godin D. Multiple Sclerosis and Related Disorders, 3rd Series. Vol. 1222014. Copyright: \u00a9 Elsevier 2014. eBook ISBN: 9780444633095"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Wilkins A. Cerebellar dysfunction in multiple sclerosis. Frontiers in Neurology. 2017;8:312. DOI: 10.3389\/fneur.2017.00312. Recollection 2017","DOI":"10.3389\/fneur.2017.00312"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Alusi SH, Worthington J, Glickman S. Bain PG A study of tremor in multiple sclerosis. Brain. 2001;124(Pt. 4):720-730","DOI":"10.1093\/brain\/124.4.720"},{"key":"ref=18","unstructured":"nationalmssociety.org"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology. 2001;50(1):121-127","DOI":"10.1002\/ana.1032"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Gastaldi M. Cerebrospinal fluid analysis and the determination of oligoclonal bands. Neurological Sciences. 2017;38(Supp. 2):217-224. DOI: 10.1007\/s10072-017-3034-2","DOI":"10.1007\/s10072-017-3034-2"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Stangel M, Fredrikson S, Meinl E, Petzold A, St\u00fcve O, Tumani H. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nature Reviews. Neurology. 2013;9(5):267-276. DOI: 10.1038\/nrneurol.2013.41. Epub 2013 Mar 26","DOI":"10.1038\/nrneurol.2013.41"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Davenport RD, Keren DF. Oligoclonal bands in cerebrospinal fluids: Significance of corresponding bands in serum for diagnosis of multiple sclerosis. Clinical Chemistry. 1988;34(4):764-765","DOI":"10.1093\/clinchem\/34.4.764"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Walsh P, Kane N, Butler S. The clinical role of evoked potentials. Journal of Neurology, Neurosurgery, and Psychiatry. 2005 Jun;76(Supp. 2):ii16-ii22","DOI":"10.1136\/jnnp.2005.068130"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Traboulsee A, Simon JH, Stone L, et al. Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR. American Journal of Neuroradiology. 2016;37(3):394-401","DOI":"10.3174\/ajnr.A4539"},{"key":"ref=25","unstructured":"Consortium of MS Centers MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-up of MS. 2018. REVISED GUIDELINES. www.mscare.org\/mri"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science. 1991;254(5035):1178-1181","DOI":"10.1126\/science.1957169"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Britze J, Frederiksen JL. Optical coherence tomography in multiple sclerosis. Eye (Lond). 2018;32:884-888. DOI: 10.1038\/s41433-017-0010-2","DOI":"10.1038\/s41433-017-0010-2"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet. 2004;364:2106-2112","DOI":"10.1016\/S0140-6736(04)17551-X"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. The Journal of Experimental Medicine. 2005;202:473-477","DOI":"10.1084\/jem.20050304"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-189. DOI: 10.1212\/WNL.0000000000001729. Epub 2015 Jun 19","DOI":"10.1212\/WNL.0000000000001729"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Johns TG, Bernard CC. The structure and function of myelin oligodendrocyte glycoprotein. Journal of Neurochemistry. 1999;72(1):1-9","DOI":"10.1046\/j.1471-4159.1999.0720001.x"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. Journal of Neurology, Neurosurgery, and Psychiatry. 2015;86:265-272","DOI":"10.1136\/jnnp-2014-308346"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Zhou D, Srivastava R, Nessler S, et al. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:19057-19062. [PMC free article] [PubMed]","DOI":"10.1073\/pnas.0607242103"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, et al. MOG-IgG in NMO and related disorders: A multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Journal of Neuroinflammation. 2016;13(1):280","DOI":"10.1186\/s12974-016-0718-0"},{"key":"ref=35","doi-asserted-by":"crossref","unstructured":"Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, et al. Acute disseminated encephalomyelitis updates on an inflammatory CNS syndrome. Neurology. 2016;87(Supp. 2):S38-45","DOI":"10.1212\/WNL.0000000000002825"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Garg RK. Acute disseminated encephalomyelitis. Postgraduate Medical Journal. 2003;79:11-17","DOI":"10.1136\/pmj.79.927.11"},{"key":"ref=37","doi-asserted-by":"crossref","unstructured":"Krupp LB, Banwell B, Tenembaum S, International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(16, supplement 2):S7-S12","DOI":"10.1212\/01.wnl.0000259422.44235.a8"},{"key":"ref=38","doi-asserted-by":"crossref","unstructured":"Krupp LB, Tardieu M, Amato MP, et al. International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Multiple Sclerosis Journal. 2013;19(10):1261-1267","DOI":"10.1177\/1352458513484547"},{"key":"ref=39","doi-asserted-by":"crossref","unstructured":"Asherson RA, Cervera R, Piette JC, Shoenfeld Y. The antiphospholipid syndrome: History, definition, classification, and differential diagnosis. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, editors. The Antiphospholipid Syndrome. Boca Raton (FL): CRC Press; 1996. pp. 3-12","DOI":"10.1016\/B978-044450987-1\/50003-6"}],"container-title":["Multiple Sclerosis [Working Title]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.intechopen.com\/download\/pdf\/66721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T05:57:35Z","timestamp":1607493455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.intechopen.com\/online-first\/diagnosis-of-multiple-sclerosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,13]]},"references-count":39,"URL":"https:\/\/doi.org\/10.5772\/intechopen.85258","relation":{},"subject":[],"published":{"date-parts":[[2019,4,13]]}}}